LONGEVITY
Clinical trials for LONGEVITY explained in plain language.
Never miss a new study
Get alerted when new LONGEVITY trials appear
Sign up with your email to follow new studies for LONGEVITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a daily pill slow cellular ageing? small study investigates
Disease control OngoingThis study tests whether a daily food supplement, taken for 30 days, can improve markers of cellular health in healthy adults aged 35 and over. The supplement contains ingredients thought to boost NAD+ levels and support energy production and antioxidant defenses. Researchers wil…
Matched conditions: LONGEVITY
Phase: NA • Sponsor: Sam Treadway • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Anti-Aging cocktail tested in small trial
Disease control OngoingThis study tests whether a combination of medications and supplements can improve healthspan in adults aged 60-80. Participants take either a control, a multi-therapy (including metformin and NAD+), or a comprehensive therapy (adding rapamycin) for 90 days. The goal is to see cha…
Matched conditions: LONGEVITY
Phase: PHASE3 • Sponsor: AgelessRx • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Can a supplement box turn back the clock? new study investigates
Knowledge-focused OngoingThis study looks at whether a daily supplement called HOP Box can improve markers of biological aging and overall health in women. Thirty-five women aged 35 to 60 will take the supplement twice a day for 90 days. Researchers will measure changes in biological age using a blood te…
Matched conditions: LONGEVITY
Phase: NA • Sponsor: Human Optimization Project • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Can supplements slow aging? small trial begins
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests the safety and biological effects of dietary supplements, starting with spermidine, in 10 healthy adults aged 18 to 75. Participants take increasing doses over three months while researchers monitor blood markers and side effects. The goal is to learn how these s…
Matched conditions: LONGEVITY
Phase: NA • Sponsor: Atria Research and Global Health Institute (ARGHI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC